Biomode
Braga
About Biomode
Biomode is a startup venture based in Caldas das Taipas (Portugal) that aims to be a leading provider of rapid and accurate molecular diagnostic tests for identification of pathogens in the food, environment and life science industries. Biomode’s diagnostic kits are based on the PNA-FISH (Peptide Nucleic Acid Fluorescence In Situ Hybridisation) technology. Biomode’s founders are a group of researchers from the universities of Minho and Porto (Portugal) that is one of the few worldwide research groups with the skills to design PNA-FISH probes targeting specific pathogens. Biomode will enter the food industry diagnostics market with a kit for detecting Salmonella in food samples (Probe4Salmonella®) soon to be followed by two other kits for the detection of Listeria monocytogenes and E. coli O157:H7. On the clinical diagnostics area, Biomode has already developed a kit aimed at the rapid identification of clarithromycin resistance of H. Pylori strains (Probe4Pylori®) that is in the process of obtaining investigational device exemption from the Food and Drug Administration (FDA) in order to undergo field trials.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.2M
- Funding stage: Early Stage Venture
- Last round: Grant (Jul 2018)
- Website: biomode-sa.com
- Phone: +351253140161
Industries & Categories
Biotechnology, Health Diagnostics, Life Science, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/biomode-2213524 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.